Evidence map›Paper›PMID 34832889›Full record

ArticlePharmaceuticals (Basel, Switzerland)2021

Initial Experience of Clinical Use of [

Jarosław B Ćwikła, Marek Roslan, Iwona Skoneczna, Monika Kempińska-Wróbel, Michał Maurin, Wojciech Rogowski, Barbara Janota, Anna Szarowicz, Piotr Garnuszek

Open access · goldAbstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Diagnostic performance ofWorld journal of clinical cases · 2025
    Article
  2. Clinical evaluation of [RSC advances · 2025
    Article
  3. Recent Progress in Synthesis ofNuclear medicine and molecular imaging · 2024
    Review
  4. [Molecules (Basel, Switzerland) · 2022
    Article
  5. Advances in PSMA theranostics.Translational oncology · 2022
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Jarosław B ĆwikłaDepartment of Cardiology and Internal Medicine, School of Medicine, University of Warmia and Mazury, 11-041 Olsztyn, Poland.
Marek RoslanDepartment of Urology, School of Medicine, University of Warmia and Mazury, 11-041 Olsztyn, Poland.ORCID 0000-0001-9794-3539
Iwona SkonecznaDepartment of Urology, Grochowski Hospital, 04-073 Warsaw, Poland.
Monika Kempińska-WróbelDepartment of Cardiology and Internal Medicine, School of Medicine, University of Warmia and Mazury, 11-041 Olsztyn, Poland.
Michał MaurinNational Centre for Nuclear Research, Radioisotope Centre POLATOM, 05-400 Otwock, Poland.ORCID 0000-0003-2102-4178
Wojciech RogowskiDepartment of Urology, Hospital Ministry of Internal Affairs, 02-507 Warsaw, Poland.
Barbara JanotaNational Centre for Nuclear Research, Radioisotope Centre POLATOM, 05-400 Otwock, Poland.
Anna SzarowiczGE Healthcare, 02-583 Warsaw, Poland.ORCID 0000-0002-7401-7636
Piotr GarnuszekNational Centre for Nuclear Research, Radioisotope Centre POLATOM, 05-400 Otwock, Poland.ORCID 0000-0003-0650-1992
National Centre for Nuclear Research · PLUniversity of Warmia and Mazury in Olsztyn · PLCentral Clinical Hospital · PLThe Maria Sklodowska-Curie National Research Institute of Oncology · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Numerous different molecules of prostate-specific membrane antigen (PSMA) ligands are used to detect prostate cancer (PCa); most approaches utilize gallium PET and a few reports describe the role of SPECT/CT. [

Indexed as

[99mTc]Tc-PSMA-T4molecular imagingprostate cancerprostate specific membrane antigen (PSMA)

Identifiers

PMID34832889
PMCPMC8623387
OpenAlexW3209582478

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.